TY - CHAP
T1 - Vasovist® for imaging ischemic and congenital heart disease
AU - Kelle, Sebastian
AU - Greil, Gerald F.
AU - Razavi, Reza
AU - Nagel, Eike
PY - 2008
Y1 - 2008
N2 - Cardiovascular MR (CMR) offers various options to detect ischemia in patients with known or suspected coronary artery disease (CAD). Over the past few years, the evidence on many indications in the diagnosis of CAD and heart failure with CMR has accumulated [1, 2]. CMR provides combined diagnostic information, such as visualization of the vascular tree, cardiac anatomy and function, as well as measurements of blood flow in the vessels, ventricular wall motion, myocardial perfusion and viability. Most of the current applications for CMR imaging use contrast agents, either to improve image quality (e.g. angiography) or to generate contrast (e.g. delayed gadolinium enhancement or perfusion).
AB - Cardiovascular MR (CMR) offers various options to detect ischemia in patients with known or suspected coronary artery disease (CAD). Over the past few years, the evidence on many indications in the diagnosis of CAD and heart failure with CMR has accumulated [1, 2]. CMR provides combined diagnostic information, such as visualization of the vascular tree, cardiac anatomy and function, as well as measurements of blood flow in the vessels, ventricular wall motion, myocardial perfusion and viability. Most of the current applications for CMR imaging use contrast agents, either to improve image quality (e.g. angiography) or to generate contrast (e.g. delayed gadolinium enhancement or perfusion).
UR - http://www.scopus.com/inward/record.url?scp=84895200709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84895200709&partnerID=8YFLogxK
U2 - 10.1007/978-3-540-77861-5_14
DO - 10.1007/978-3-540-77861-5_14
M3 - Chapter
AN - SCOPUS:84895200709
SN - 9783540778608
SP - 159
EP - 168
BT - Clinical Blood Pool MR Imaging
PB - Springer Berlin Heidelberg
ER -